-
Crew splashes down after 8-month mission on International Space Station
-
Ex-prince Andrew raid warrants ruled 'unlawful' but UK police maintain probe
-
Protests, clashes as S. African anti-migrant tensions reignite
-
Two Latvians arrested inside UK military base: police
-
Russian data centre hit by drone in first for Ukraine war
-
Eckert 'forever grateful' for Southampton support over spy scandal
-
'Fighting for our future': France high school students vow no let-up
-
Venezuela's Maduro, wife hit with new US torture charges
-
Kyiv entering 'survival' mode amid Russian strikes surge: mayor tells AFP
-
Argentina friendlies no fairy tale for African footballers
-
Verdict due in Mexico trial over murders of Australia, US surfers
-
US suspending Microsoft from visa program: Vance
-
B2PRIME Welcomes Christina Barbash as Commercial Manager
-
Man City must 'stick together' during crisis, says Haaland
-
Russia forcing Kyiv into 'survival' mode before winter, mayor tells AFP
-
CAS opens hearing into Senegal AFCON title appeal
-
Closing arguments begin in Maradona death trial
-
UK police agree searches for ex-prince Andrew's homes 'unlawful': judge
-
UEFA president Ceferin to stand for re-election in 2027
-
After botched US execution, Christa Pike walking, mentally 'foggy': lawyer
-
Nearly 300,000 Nepalis at flood risk: study
-
'Stunned' Madrid mourns pensioner who sparked housing protests
-
Riyadh kindergarten hit by interception debris as Houthis say targeted airport
-
High school students turn out for new protests across France
-
Alex Bodi mizează, alături de CRIF, pe investiții transparente și pe prevenirea riguroasă a spălării banilor
-
Bid by Italy's Intesa bank to take over MPS gets boost
-
Gulf Labs, Part of Thailand’s $27 Billion GULF Group, Goes Live as an Injective Validator
-
Stablecoins Are Quietly Becoming Business Infrastructure, NOWPayments Data Shows
-
EU okay for winter despite 'historically low' gas stocks: operators
-
Oil surges, stocks sink as US reportedly eyes new Iran strikes
-
Rwanda to host F1 Grand Prix: sources close to both sides
-
Woman in botched US execution walking, mentally 'foggy': lawyer
-
EU top diplomat says bloc in favour of UN Lebanon peacekeepers' extension
-
Farhan hopes Pakistan's new combination takes off in Sri Lanka T20Is
-
Antonelli and Russell to run different Mercedes aero packages in Singapore
-
Teenager Andreeva seals China Open semi-final with Bartunkova
-
WTO hikes 2026 trade growth forecast on AI boom
-
Britain's Burnham says open to Germany joining warplane project
-
'I love that challenge': Hamilton prays for rain in Singapore
-
Kovac's tough love has Dortmund dreaming of title charge
-
G.Bissau moves towards postponement of December general election
-
China announces candidate for WHO chief
-
Verstappen out to settle 'unfinished business' at Singapore Grand Prix
-
South Korea test-fires its first homegrown hypersonic weapon: presidency
-
WhiteBIT Launches Bitcoin Lightning Network Support, Powered by Voltage
-
ONAR Advances Nasdaq Listing Preparation Following Advertise Purple Acquisition and Financing
-
Oil surges, stocks sink as US reportedly eyes fresh Iran strikes
-
Thailand opens extradition process for reporter sought by China
-
Anne Carson: modern takes on Greek classics
-
France struggles to wean social housing off gas
Trump announces plan aimed at improving IVF accessibility
Donald Trump on Thursday announced a plan aimed at making in vitro fertilization more affordable, an initial step in a long-touted campaign promise.
Earlier this year Trump dubbed himself the "fertilization president" and has vowed to address IVF accessibility, an effort that has sowed division within his base between pro-natalist members and conservative Christians.
Substantive coverage of fertility-related procedures and medications in the United States remains rare and highly variable depending on specific patients, providers, employers and state rules.
It was unclear what concrete changes the initiative could lead to. But Trump said in Oval Office remarks that "prices are going way down. Way, way down."
Trump said the White House is proposing a so-called employer benefit option they say would encourage employers to offer workers coverage for IVF through a supplemental plan.
That would be similar to how dental and vision care are frequently managed in the United States -- carved out of the core medical insurance and covered as a standalone type of care.
"I'm asking all employers to make these new fertility benefit options available to their employees immediately," Trump said.
Senior administration officials told journalists there was no discussion of creating subsidies that would incentivize employers to provide IVF benefits, nor was it mandating they do so.
A typical round of IVF treatment -- patients must frequently endure multiple rounds to achieve a viable pregnancy -- can cost tens of thousands of dollars. Necessary prescription drug costs alone can set back hopeful parents by the thousands.
The Trump administration's announcement included a proposal to make some of those drugs available for patients to purchase directly from manufacturers at discounted rates, via the president's new website TrumpRx, starting in early 2026.
Trump's IVF efforts have emerged as a dividing line among competing groups within his own base.
Many Christian conservatives voice staunch opposition to IVF, primarily because it can involve discarding human embryos.
Trump side-stepped the issue when queried about it Thursday.
"I think this is very pro-life," he said. "You can't get more pro-life than this."
About a quarter of US employers with 200 workers or more currently offer health plans that include at least some IVF coverage, according to the KFF health policy research organization.
Some states require private insurers to include services in their plans. And some states require Medicaid, the government program for low-income individuals, to include some benefits related to fertility.
TJ Farnsworth -- the head of Inception Fertility, a providers alliance -- welcomed the White House efforts, but said it is on employers to consider what they offer.
"I just think it's really important that people realize that this is an amazing start to the conversation, but it's not likely to have an immediate impact to patients," Farnsworth told AFP.
J.Bergmann--BTB